BUD
NEUTRAL
$69.88
Live
Anheuser-Busch InBev SA/NV · NYSE
Target $78.1
(+11.8%)
$47.89
52W Range
$72.13
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 24, 2026
Market cap
$135.98B
P/E
23.22
ROE
N/A
Profit margin
10.4%
Debt/Equity
0.83
Dividend yield
1.86%
AI Analysis
AI-powered fundamental assessment
Confidence
65%
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant operational and profitability concerns. Despite this, the stock trades above its Graham Number of $52.90 at $69.88, supported by a bullish analyst recommendation and strong recent price performance. Earnings growth has collapsed year-over-year (-48.6%), yet the company consistently beats estimates, showing some earnings quality. Profit margins and cash flow generation remain solid, but missing key financial health metrics like ROE, ROA, and Altman Z-Score limits confidence in stability. The dividend is sustainable with a 37.5% payout ratio, but insider sentiment and technical trend are weak.
Key Strengths
Consistent earnings beat streak with 3 out of last 4 quarters exceeding estimates and a 5.93% average surprise
High gross margin of 55.90% reflects strong pricing power and cost control in brewing operations
Solid operating margin at 27.79%, outperforming sector average profit margin of -1.59%
Debt/Equity of 0.83 is below sector average of 1.73, indicating relatively conservative leverage
Analyst target price of $78.10 implies 11.8% upside, with unanimous buy recommendation from 10 analysts
Key Risks
Critically low Piotroski F-Score of 2/9 signals deteriorating financial health and weak earnings quality
Earnings growth has collapsed YoY (-48.6%) and QoQ (-49.1%), raising sustainability concerns
Missing key financial health data (ROE, ROA, Altman Z-Score, cash/debt figures) creates opacity and risk
Technical trend score of 10/100 indicates strong bearish momentum despite long-term price gains
Forward P/E of 16.74 is optimistic given near-zero revenue growth (0.6% YoY) and declining earnings
AI Fair Value Estimate
Based on comprehensive analysis
$58.0
-17.0% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
48
Moderate
45
40
60
30
65
AI Verdict
Neutral with upside risk if earnings stabilize
Key drivers: Low Piotroski score dragging down health, Strong margins and earnings beat consistency providing support, Analyst optimism offsetting weak technicals, Valuation stretched relative to growth
Confidence
65%
Value
45/100
Ref P/E, PEG, Graham Number
Positives
- P/E of 23.22 below sector average of 29.29
- Forward P/E of 16.74 suggests de-rating on growth concerns
Watchpoints
- Current price 32% above Graham Number ($52.90)
- No PEG ratio due to negative earnings growth
- Intrinsic value estimate of $21.07 implies deep overvaluation
Future
40/100
Ref Growth rates
Positives
- Forward P/E contraction suggests market expects recovery
- Analyst target implies confidence in future earnings rebound
Watchpoints
- Revenue growth of 0.6% YoY is minimal
- Earnings growth down -48.6% YoY
- Q/Q earnings down -49.1%, indicating ongoing deterioration
Past
60/100
Ref Historical trends
Positives
- Long history of beating earnings estimates (22 out of 25 quarters)
- 1Y price return of +47.5% outperforms most peers
- 5Y return of +15.0% shows resilience
Watchpoints
- Recent earnings surprises driven by low baselines (e.g., $0.13 est to $0.61 actual)
- 6M return of -0.5% shows recent stagnation
Health
30/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Debt/Equity of 0.83 is manageable
- Profit margin of 10.4% remains positive
Watchpoints
- Piotroski F-Score of 2/9 indicates severe financial weakness
- Missing Altman Z-Score, ROE, ROA, and liquidity ratios
- No data on cash flow or debt maturity profile
Dividend
65/100
Ref Yield, Payout
Positives
- Dividend yield of 1.86% is modest but stable
- Payout ratio of 37.48% is sustainable
- Dividend strength score of 40/100 suggests room for improvement
Watchpoints
- No 5-year yield average to assess consistency
- No ex-dividend date provided, limiting transparency
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$69.88
Analyst Target
$78.1
Upside/Downside
+11.8%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for BUD and closest competitors.
Updated 2026-01-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
BUD
Anheuser-Busch InBev SA/NV
Primary
|
+15.0% | +23.0% | +47.5% | -0.5% | +9.5% | +1.9% |
|
BTI
British American Tobacco p.l.c.
Peer
|
+131.6% | +96.1% | +69.8% | +16.4% | +4.7% | +1.6% |
|
MDLZ
Mondelez International, Inc.
Peer
|
+7.3% | -18.6% | -8.9% | -5.2% | -0.6% | +0.2% |
|
MNST
Monster Beverage Corporation
Peer
|
+70.6% | +45.3% | +27.4% | +13.4% | +3.9% | +2.3% |
|
CL
Colgate-Palmolive Company
Peer
|
+2.2% | +11.3% | -12.6% | -13.4% | +1.2% | -0.9% |
BUD
Anheuser-Busch InBev SA/NV
Primary
5Y
+15.0%
3Y
+23.0%
1Y
+47.5%
6M
-0.5%
1M
+9.5%
1W
+1.9%
BTI
British American Tobacco p.l.c.
Peer
5Y
+131.6%
3Y
+96.1%
1Y
+69.8%
6M
+16.4%
1M
+4.7%
1W
+1.6%
MDL
Mondelez International, Inc.
Peer
5Y
+7.3%
3Y
-18.6%
1Y
-8.9%
6M
-5.2%
1M
-0.6%
1W
+0.2%
MNS
Monster Beverage Corporation
Peer
5Y
+70.6%
3Y
+45.3%
1Y
+27.4%
6M
+13.4%
1M
+3.9%
1W
+2.3%
CL
Colgate-Palmolive Company
Peer
5Y
+2.2%
3Y
+11.3%
1Y
-12.6%
6M
-13.4%
1M
+1.2%
1W
-0.9%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
23.22
Forward P/E
16.74
PEG Ratio
N/A
P/B Ratio
1.69
P/S Ratio
2.32
EV/Revenue
3.68
EV/EBITDA
11.41
Market Cap
$135.98B
Profitability
Profit margins and return metrics
Profit Margin
10.41%
Operating Margin
27.79%
Gross Margin
55.91%
ROE
N/A
ROA
N/A
Growth
Revenue and earnings growth rates
Revenue Growth
+0.6%
Earnings Growth
-48.6%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
-49.1%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.83
Moderate
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$3.77
Quarterly Earnings History
EPS performance vs analyst estimates
2026-02-12
$N/A
2025-10-30
$0.99
+3.9% surprise
2025-07-31
$0.98
+3.5% surprise
2025-05-08
$0.81
+10.4% surprise
Consumer Defensive Sector Comparison
Comparing BUD against 170 companies in the Consumer Defensive sector
(9 bullish, 60 neutral, 101 bearish)
P/E Ratio
23.22
This Stock
vs
37.45
Sector Avg
-38.0%
(Discount)
Profit Margin
10.41%
This Stock
vs
-7.77%
Sector Avg
-233.9%
(Weaker)
Debt to Equity
0.83
This Stock
vs
1.89
Sector Avg
-56.0%
(Less Debt)
Revenue Growth
0.6%
This Stock
vs
111.74%
Sector Avg
-99.5%
(Slower)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
BUD
Anheuser-Busch InBev SA/NV
|
NEUTRAL | $135.98B | 23.22 | -% | 10.4% | $69.88 | |
|
BTI
British American Tobacco p.l.c.
|
NEUTRAL | $128.41B | 31.47 | 6.3% | 12.1% | $59.16 | Compare |
|
MDLZ
Mondelez International, Inc.
|
NEUTRAL | $73.7B | 30.38 | 9.3% | 6.4% | $57.42 | Compare |
|
MNST
Monster Beverage Corporation
|
BULLISH | $69.67B | 40.52 | 25.5% | 21.7% | $71.31 | Compare |
|
CL
Colgate-Palmolive Company
|
NEUTRAL | $63.51B | 21.86 | 293.6% | 14.5% | $78.05 | Compare |
BUD
Anheuser-Busch...
NEUTRAL
Mkt Cap
$136.0B
P/E
23.2
ROE
-%
Price
$69.88
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
10 analysts
Wells Fargo
2025-11-19
Overweight
Past News Coverage
Recent headlines mentioning BUD from our newsroom.
Newest → oldest
No matching news yet.